Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

305.77 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 130
Open 305.77
Bid (Size) 303.06 (1)
Ask (Size) 306.55 (1)
Prev. Close 305.77
Today's Range 305.77 - 305.77
52wk Range 253.30 - 346.85
Shares Outstanding N/A
Dividend Yield 2.94%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is the Market Bullish or Bearish on Amgen?
Via Benzinga
Why Pharma and Biotech Stocks Got Thrashed on Tuesday
Via The Motley Fool

Performance

YTD
+17.9%
+17.9%
1 Month
-3.1%
-3.1%
3 Month
+16.2%
+16.2%
6 Month
-4.2%
-4.2%
1 Year
+6.8%
+6.8%

More News

Read More
Amgen Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Amgen's Options: A Look at What the Big Money is Thinking
Via Benzinga
Assessing Amgen: Insights From 9 Financial Analysts
Via Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Via Benzinga
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress
Via Benzinga
Behind the Scenes of Amgen's Latest Options Trends
Via Benzinga
Behind the Scenes of Amgen's Latest Options Trends
Via Benzinga
Prediction: These 2 Stocks Will Outperform the Market Through 2030
Via The Motley Fool
Motley Fool Market Cap Showdown: Bill Barker vs. Emily Flippen
Via The Motley Fool
Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year
Via Benzinga
Is Eli Lilly Stock a Buy?
Via The Motley Fool
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study
Via Benzinga
3 Magnificent Growth Stocks to Buy in March
Via The Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
Via The Motley Fool
2 Reasons to Watch AMGN and 1 to Stay Cautious
Via StockStory
Topics Stocks
Exposures US Equities
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
Via Benzinga
AMGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Amgen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
Via Benzinga
Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
This Could Be the Best GLP-1 Stock to Buy in 2025
Via The Motley Fool

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 305.77
When was Amgen last traded?
The last trade of Amgen was at 03/27/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.